L-282-2023
Agreement ID
L-282-2023
Lead IC
NCATS
Exclusivity
Exclusive
External Party
Platform Pharmaceuticals, Inc.
Fiscal Year
2024
Territory
Worldwide
Execution Date
Effective Date
Export Date